Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.coph.2013.08.006PMID 23978504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GPR43/FFA2: physiopathological relevance and therapeutic prospects.

  2013cited by this paper
• Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

  2013cited by this paper
• Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury.

  2013cited by this paper
• The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function.

  2013cited by this paper
• Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.

  2012cited by this paper
• Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.

  2012cited by this paper
• The human microbiome: at the interface of health and disease

  2012cited by this paper
• Diversity, stability and resilience of the human gut microbiota

  2012cited by this paper
• Structure, Function and Diversity of the Healthy Human Microbiome

  2012cited by this paper
• Prebiotics, probiotics and digestive health

  2012cited by this paper
• A novel therapeutic target, GPR43; Where it stands in drug discovery

  2012cited by this paper
• Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives.

  2012cited by this paper
• Biological and pharmacological roles of HCA receptors.

  2011cited by this paper
• Regulation of Inflammation by Short Chain Fatty Acids

  2011cited by this paper
• G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer

  2011cited by this paper
• Synbiotics in health and disease.

  2011cited by this paper
• Breakthrough of the year. The runners-up.

  2011cited by this paper
• Intestinal health functions of colonic microbial metabolites: a review.

  2011cited by this paper
• Human nutrition, the gut microbiome and the immune system

  2011cited by this paper
• Colonic Gene Expression in Conventional and Germ-Free Mice with a Focus on the Butyrate Receptor GPR109A and the Butyrate Transporter SLC5A8

  2010cited by this paper
• Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases.

  2010cited by this paper
• Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases

  2010cited by this paper
• Propionate-induced epithelial K+ and Cl−/HCO3− secretion and free fatty acid receptor 2 (FFA2, GPR43) expression in the guinea pig distal colon

  2010cited by this paper
• Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation

  2010cited by this paper
• GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.

  2009cited by this paper
• Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

  2009cited by this paper
• Lactaturia and Loss of Sodium-dependent Lactate Uptake in the Colon of SLC5A8-deficient Mice*

  2008cited by this paper
• Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions.

  2008cited by this paper
• Sodium-Coupled Transport of the Short Chain Fatty Acid Butyrate by SLC5A8 and Its Relevance to Colon Cancer

  2008cited by this paper
• Transport of Nicotinate and Structurally Related Compounds by Human SMCT1 (SLC5A8) and Its Relevance to Drug Transport in the Mammalian Intestinal Tract

  2007cited by this paper
• The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.

  2006cited by this paper
• Short-chain fatty acids: ready for prime time?

  2006cited by this paper
• Colonic Health: Fermentation and Short Chain Fatty Acids

  2006cited by this paper
• (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G*

  2005cited by this paper
• The human tumour suppressor gene SLC5A8 expresses a Na+–monocarboxylate cotransporter

  2004cited by this paper
• Expression of slc5a8 in Kidney and Its Role in Na+-coupled Transport of Lactate*

  2004cited by this paper
• Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids*

  2004cited by this paper
• PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

  2003cited by this paper
• SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

  2003cited by this paper
• Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid*

  2003cited by this paper
• Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?

  2003cited by this paper
• PUMA‐G, an IFN‐γ‐inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily

  2001cited by this paper

• Effects of enteric Prevotella on host health and disease: An overview of its double-edged roles and future perspectives

  2026cites this paper
• Health Benefits of Polysaccharides in Red Algae: A Comprehensive Review

  2026cites this paper
• Advances in the study of gut microecology and mechanisms of hyperuricemia and gouty arthritis

  2026cites this paper
• Changes in the microbiota following allogeneic hematopoietic stem cell transplantation: A potential bioguide for clinical outcome?

  2025cites this paper
• Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status

  2025cites this paper
• Not Just an Alternative Energy Source: Diverse Biological Functions of Ketone Bodies and Relevance of HMGCS2 to Health and Disease

  2025cites this paper
• Gut Microbiota and Gastric Cancer: The Immunoregulatory Mechanism and the Preventive Role of Microbiota‐Derived Short‐Chain Fatty Acids

  2025cites this paper
• Potential role of short-chain fatty acids in the development of extraintestinal manifestations of Crohn’s disease

  2025cites this paper
• Dose-Dependent Effects of Short-Chain Fatty Acids on 3T3-L1 Adipocyte Adipokine Secretion and Metabolic Function

  2025cites this paper
• Reprogramming CAR-T cells: Targeting SLC transporters for tumor microenvironment adaptation.

  2025cites this paper
• Lipids in Clinical Nutrition and Health: Narrative Review and Dietary Recommendations

  2025cites this paper
• Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics

  2025cites this paper
• Impact of non-digestible carbohydrates and prebiotics on immunity, infections, inflammation and vaccine responses: a systematic review of evidence in healthy humans and a discussion of mechanistic proposals

  2025cites this paper
• Diet-induced changes in the colonic microenvironment reduce polyp development in APCMin/+Msh2-/- mice by triggering ER stress

  2025cites this paper
• Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers

  2025cites this paper
• The Role of Butyric Acid and Microorganisms in Chronic Inflammatory Diseases and Microbiome-Based Therapeutics

  2025cites this paper
• Microbiota and beneficial metabolites in colorectal cancer.

  2024cites this paper
• Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.

  2024cites this paper
• Colonic ketogenesis, a microbiota-regulated process, contributes to blood ketones and protects against colitis in mice

  2024cites this paper
• The roles of ABCB1/P-glycoprotein drug transporters in regulating gut microbes and inflammation: insights from animal models, old and new

  2024cites this paper
• Effect of bioactive compounds in processed Camellia sinensis tea on the intestinal barrier.

  2024cites this paper
• Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents—challenges and limitations

  2024cites this paper
• Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.

  2024cites this paper
• Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction

  2024cites this paper
• Study on the effects of intestinal flora on gouty arthritis

  2024cites this paper
• Autoinducer-2 promotes the colonization of Lactobacillus rhamnosus GG to improve the intestinal barrier function in a neonatal mouse model of antibiotic-induced intestinal dysbiosis

  2024cites this paper
• Effect of Short-Chain Fatty Acids on Inflammatory and Metabolic Function in an Obese Skeletal Muscle Cell Culture Model

  2024cites this paper
• Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)

  2024cites this paper
• Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women

  2024cites this paper
• Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression

  2024cites this paper
• Noval advance of histone modification in inflammatory skin diseases and related treatment methods

  2024cites this paper
• Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer

  2024cites this paper
• Endocrine Properties of Microbiota

  2024cites this paper
• Current understanding of free fatty acids and their receptors in colorectal cancer treatment.

  2024cites this paper
• Lactucin reverses liver fibrosis by inhibiting TGF-β1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism

  2024cites this paper
• Pathogenesis of gout: Exploring more therapeutic target

  2024cites this paper
• Effect of Comparable Carbon Chain Length Short- and Branched-Chain Fatty Acids on Adipokine Secretion from Normoxic and Hypoxic Lipopolysaccharide-Stimulated 3T3-L1 Adipocytes

  2024cites this paper
• Butyrate reduction and HDAC4 increase underlie maternal high fructose-induced metabolic dysfunction in hippocampal astrocytes in female rats.

  2024cites this paper
• Comparison of the fecal bacterial microbiota in mice, rats, and pigs after oral administration of alpha-glycosyl isoquercitrin.

  2024cites this paper
• Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

  2023cites this paper
• Diversity of fibers in common foods: Key to advancing dietary research

  2023cites this paper
• Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease.

  2023cites this paper
• Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections

  2023cites this paper
• The gut microbiome as a factor in the development of Parkinson's disease

  2023cites this paper
• Disease mechanisms as subtypes: Microbiome.

  2023cites this paper
• Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.

  2023cites this paper
• The causal relationship between gut microbiota and leukemia: a two-sample Mendelian randomization study

  2023cites this paper
• Acetate Upregulates GPR43 Expression and Function via PI3K-AKT-SP1 Signaling in Mammary Epithelial Cells during Milk Fat Synthesis.

  2023cites this paper
• The Triple Alliance: Microbiome, Mitochondria, and Metabolites in the Context of Age-Related Cognitive Decline and Alzheimer's Disease.

  2023cites this paper
• In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles

  2023cites this paper
• Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases

  2023cites this paper
• Mitigation of Insulin Resistance by Natural Products from a New Class of Molecules, Membrane-Active Immunomodulators

  2023cites this paper
• Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms.

  2023cites this paper
• Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?

  2023cites this paper
• Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer

  2023cites this paper
• The Promise of Niacin in Neurology

  2023cites this paper
• Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms

  2023cites this paper
• Does Gut Brain Axis has an impact on Parkinson's Disease (PD)?

  2023cites this paper
• Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells

  2023cites this paper
• Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?

  2023cites this paper
• Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate

  2022cites this paper
• Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Effect of different dosages of sodium butyrate and niacin on growth, faecal microbiota and Vitamin B metabolism in weaned piglets

  2022cites this paper
• Multi-Omic Analyses Reveal Bifidogenic Effect and Metabolomic Shifts in Healthy Human Cohort Supplemented With a Prebiotic Dietary Fiber Blend

  2022cites this paper
• The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy

  2022cites this paper
• Alteration of Gut Microbiota in Alzheimer’s Disease and Their Relation to the Cognitive Impairment

  2022cites this paper
• The Role of Diet in Influencing the Diversity of Gut Microbiome Related to Lupus Disease Activities: A Systematic Review

  2022cites this paper
• Butyrate Ameliorates Intraocular Bacterial Infection by Promoting Autophagy and Attenuating the Inflammatory Response

  2022cites this paper
• Role of microbiome and its metabolite, short chain fatty acid in prostate cancer

  2022cites this paper
• The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome

  2022cites this paper
• Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues

  2022cites this paper
• Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease

  2022cites this paper
• Genomic reconstruction of short-chain fatty acid production by the human gut microbiota

  2022cites this paper
• Phenotypic and Genomic Diversification in Complex Carbohydrate-Degrading Human Gut Bacteria

  2022cites this paper
• Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment

  2022cites this paper
• The role of OR51E2 in colon cancer and rectal adenocarcinoma and the potential underlying mechanism

  2022cites this paper
• The Gut Microbiome and Ferroptosis in MAFLD

  2022cites this paper
• Differential Effects of Short-Chain Fatty Acids on L6 Myotube Inflammatory Mediator Production in Response to Lipopolysaccharide- or Palmitic Acid-Stimulation

  2022cites this paper
• Gut microbiome in gastrointestinal cancer: a friend or foe?

  2022cites this paper
• Enzymatic cyclodextrin synthesis-tributyrin inclusion complex: Properties, structural characterization and release behaviors in vitro

  2022cites this paper
• Immunomodulation by foods and microbes: Unravelling the molecular tango

  2022cites this paper
• Endocrine Disruption and the Gut Microbiome

  2022cites this paper
• Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS

  2022cites this paper
• Effects of niacin on intestinal epithelial Barrier, intestinal Immunity, and microbial community in weaned piglets challenged by PDCoV.

  2022cites this paper
• Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease

  2022cites this paper
• Preventing and Treating of Parkinson’s Disease with a Plant-Based Diet

  2021cites this paper
• A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood–Brain Barrier Endothelial Cell Line hCMEC/D3

  2021cites this paper
• Gut microorganisms and neurological disease perspectives

  2021cites this paper
• Gut microbiota in Parkinson’s disease patients: hospital-based study

  2021cites this paper
• Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease

  2021cites this paper
• Editorial: Human Microbiome: Symbiosis to Pathogenesis

  2021cites this paper
• Colorectal Cancer and Microbiota Modulation for Clinical Use. A Systematic Review

  2021cites this paper
• Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.

  2021cites this paper
• Histone deacetylase inhibitors regulate vitamin C transporter functional expression in intestinal epithelial cells.

  2021cites this paper
• Lactobacillus plantarum GKM3 Promotes Longevity, Memory Retention, and Reduces Brain Oxidation Stress in SAMP8 Mice

  2021cites this paper
• Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa

  2021cites this paper
• Phenotypic and genomic diversification in complex carbohydrate degrading human gut bacteria

  2021cites this paper
• The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease

  2021cites this paper
• Dental biofilm microbiota dysbiosis is associated with the risk of aGVHD after allogeneic HSCT

  2021cites this paper
• Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis

  2021cites this paper